Oral P. gingivalis impairs gut permeability and mediates immune responses associated with neurodegeneration in LRRK2 R1441G mice
Open accessPublished version of a preprint
The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Background: The R1441G mutation in the leucine-rich repeat kinase 2 (LRRK2) gene results in late-onset Parkinson’s disease (PD). Peripheral inflammation and gut microbiota are closely associated with the pathogenesis of PD. Chronic periodontitis is a common type of peripheral inflammation, which is associated with PD. Porphyromonas gingivalis (Pg), the most common bacterium causing chronic periodontitis, can cause alteration of gut microbiota. It is not known whether Pg-induced dysbiosis plays a role in the pathophysiology of PD. Methods: In this study, live Pg were orally administrated to animals, three times a week for 1 month. Pg-derived lipopolysaccharide (LPS) was used to stimulate mononuclear cells in vitro. The effects of oral Pg administration on the gut and brain were evaluated through behaviors, morphology, and cytokine expression. Results: Dopaminergic neurons in the substantia nigra were reduced, and activated microglial cells were increased in R1441G mice given oral Pg. In addition, an increase in mRNA expression of tumor necrosis factor (TNF-α) and interleukin-1β (IL-1β) as well as protein level of α-synuclein together with a decrease in zonula occludens-1 (Zo-1) was detected in the colon in Pg-treated R1441G mice. Furthermore, serum interleukin-17A (IL-17A) and brain IL-17 receptor A (IL-17RA) were increased in Pg-treated R1441G mice. Conclusions: These findings suggest that oral Pg-induced inflammation may play an important role in the pathophysiology of LRRK2-associated PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Porphyromonas gingivalis-induced peripheral inflammation altered the gut microbiota, increased gut permeability and microglial activation and reduced dopaminergic neurons in the substantia nigra in a genetic mouse model of Parkinson's disease.100”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [100]
Experimental — accuracy not yet measuredIn the citing paper
“Moreover, mice receiving Porphyromonas gingivalis, a pathogen associated with chronic periodontitis, showed sustained colon TNF-α and IL-1β expression, as well as higher levels of serum IL-17A and its receptor (IL-17AR) in the brain, which were associated with loss of dopaminergic neurons, α -synuclein accumulation and microglia activation [502].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [502]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A. (2007) · Nature Medicine · doi:10.1038/nm1651 · Cited by 1,759 · cited 1×
“Peripheral IL-17A has been reported to disrupt and cross the blood-brain barrier [52].”
BackgroundKim, S., Kwon, S.-H., Kam, T.-I., Panicker, N., Karuppagounder, S. S., Lee, S., Lee, J. H., Kim, W. R., Kook, M., Foss, C. A., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.05.035 · Cited by 1,397 · cited 1×
“This is in contrast to a recent observation that injection of αsynuclein fibrils in the gut mediates the spread of pathologic α-synuclein in the brain via the vagus nerve [41].”
ResultIn vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Oertel, W., Banati, R. B., & Brooks, D. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.002 · Cited by 1,200
Maes, M. H. J., Kubera, M., & Leunis, J. (2008) · PubMed · Cited by 740
The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?
Houser, M. C., & Tansey, M. G. (2017) · npj Parkinson's Disease · doi:10.1038/s41531-016-0002-0 · Cited by 588
Arimatsu, K., Yamada, H., Miyazawa, H., Minagawa, T., Nakajima, M., Ryder, M. I., Gotoh, K., Motooka, D., Nakamura, S., Iida, T., et al. (2014) · Scientific Reports · doi:10.1038/srep04828 · Cited by 573
The Familial Parkinsonism Gene LRRK2 Regulates Neurite Process Morphology
MacLeod, D., Dowman, J., Hammond, R., Leete, T., Inoue, K., & Abeliovich, A. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.008 · Cited by 564
Preshaw, P. M., & Taylor, J. J. (2011) · Journal of Clinical Periodontology · doi:10.1111/j.1600-051x.2010.01671.x · Cited by 422
Dilger, R. N., & Johnson, R. W. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0208108 · Cited by 391
Nakajima, M., Arimatsu, K., Kato, T., Matsuda, Y., Minagawa, T., Takahashi, N., Ohno, H., & Yamazaki, K. (2015) · PLOS ONE · doi:10.1371/journal.pone.0134234 · Cited by 382
Liu, Z., Lee, J., Krummey, S., Lu, W., Cai, H., & Lenardo, M. J. (2011) · Nature Immunology · doi:10.1038/ni.2113 · Cited by 361
The role of IL-17 in CNS diseases
Waisman, A., Hauptmann, J., & Regen, T. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1402-7 · Cited by 340
Pott Godoy, M. C., Tarelli, R., Ferrari, C. C., Sarchi, M. I., & Pitossi, F. J. (2008) · Brain · doi:10.1093/brain/awn101 · Cited by 335
Th17 lymphocytes induce neuronal cell death in a human iPSC-based model of Parkinson's disease
Sommer, A., Marxreiter, F., Krach, F., Fadler, T., Grosch, J., Maroni, M., Graef, D., Eberhardt, E., Riemenschneider, M. J., Yeo, G. W., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.06.015 · Cited by 332 · cited 3×
“Furthermore, IL-17A could induce human induced pluripotent stem cell-derived midbrain neuronal cell death, possibly through IL-17 receptor A (IL-17RA) [20, 21].”
BackgroundBlasco-Baque, V., Garidou, L., Pomié, C., Escoula, Q., Loubieres, P., Le Gall-David, S., Lemaitre, M., Nicolas, S., Klopp, P., Waget, A., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-309897 · Cited by 320
Khan, N. L., Jain, S., Lynch, J. M., Pavese, N., Abou-Sleiman, P., Holton, J. L., Healy, D. G., Gilks, W. P., Sweeney, M. G., Ganguly, M., et al. (2005) · Brain · doi:10.1093/brain/awh667 · Cited by 317
The Human IL-17F/IL-17A Heterodimeric Cytokine Signals through the IL-17RA/IL-17RC Receptor Complex
Wright, J. F., Bennett, F., Li, B., Brooks, J., Luxenberg, D. P., Whitters, M. J., Tomkinson, K. N., Fitz, L. J., Wolfman, N. M., Collins, M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2799 · Cited by 316
Involvement of Interferon-γ in Microglial-Mediated Loss of Dopaminergic Neurons
Mount, M. P., Lira, A., Grimes, D., Smith, P. D., Faucher, S., Slack, R., Anisman, H., Hayley, S., & Park, D. S. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5321-06.2007 · Cited by 315
Kelly, L. P., Carvey, P. M., Keshavarzian, A., Shannon, K. M., Shaikh, M., Bakay, R. A. E., & Kordower, J. H. (2014) · Movement Disorders · doi:10.1002/mds.25736 · Cited by 308 · cited 1×
“In PD, α-synuclein is considered to play a pivotal role in brain-gut-microbiota axis interactions [34, 37].”
BackgroundTomás, I., Diz, P., Tobías, A., Scully, C., & Donos, N. (2012) · Journal of Clinical Periodontology · doi:10.1111/j.1600-051x.2011.01784.x · Cited by 291 · cited 1×
“Pg is an oral pathogen that is known to be able to induce a systemic inflammatory response [43, 44].”
BackgroundHakimi, M., Selvanantham, T., Swinton, E., Padmore, R. F., Tong, Y., Kabbach, G., Venderova, K., Girardin, S. E., Bulman, D. E., Scherzer, C. R., et al. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0653-2 · Cited by 283
IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis
Huber, M., Heink, S., Pagenstecher, A., Reinhard, K., Ritter, J., Visekruna, A., Guralnik, A., Bollig, N., Jeltsch, K., Heinemann, C., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci63681 · Cited by 254
Th17 Cytokines and the Gut Mucosal Barrier
Blaschitz, C., & Raffatellu, M. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9368-7 · Cited by 248
Bermejo, D. A., Jackson, S. W., Gorosito-Serran, M., Acosta-Rodriguez, E. V., Amezcua-Vesely, M. C., Sather, B. D., Singh, A. K., Khim, S., Mucci, J., Liggitt, D., et al. (2013) · Nature Immunology · doi:10.1038/ni.2569 · Cited by 237
Gillardon, F., Schmid, R., & Draheim, H. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.02.001 · Cited by 222
Liu, Z., Qiu, A.-W., Huang, Y., Yang, Y., Chen, J.-N., Gu, T.-T., Cao, B.-B., Qiu, Y.-H., & Peng, Y.-P. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.07.026 · Cited by 207
Self-citationEvolving basic, pathological and clinical concepts in PD
Kalia, L. V., & Lang, A. E. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.249 · Cited by 206
A Missense LRRK2 Variant Is a Risk Factor for Excessive Inflammatory Responses in Leprosy
Fava, V. M., Manry, J., Cobat, A., Orlova, M., Van Thuc, N., Ba, N. N., Thai, V. H., Abel, L., Alcaïs, A., Schurr, E., et al. (2016) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0004412 · Cited by 204
G2019S-LRRK2 Expression Augments -Synuclein Sequestration into Inclusions in Neurons
Volpicelli-Daley, L. A., Abdelmotilib, H., Liu, Z., Stoyka, L., Daher, J. P. L., Milnerwood, A. J., Unni, V. K., Hirst, W. D., Yue, Z., Zhao, H. T., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.3642-15.2016 · Cited by 185
LRRK2 promotes the activation of NLRC4 inflammasome during Salmonella Typhimurium infection
Liu, W., Liu, X., Li, Y., Zhao, J., Liu, Z., Hu, Z., Wang, Y., Yao, Y., Miller, A. W., Su, B., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20170014 · Cited by 165
Self-citationSun, J., Zhang, S., Zhang, X., Zhang, X., Dong, H., & Qian, Y. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0394-5 · Cited by 148
Takagawa, T., Kitani, A., Fuss, I., Levine, B., Brant, S. R., Peter, I., Tajima, M., Nakamura, S., & Strober, W. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan8162 · Cited by 145 · cited 1×
“Interestingly, LRRK2 has been also linked to several systemic inflammatory diseases, such as inflammatory bowel disease and leprosy [7, 8].”
BackgroundParkinson’s Disease: A Systemic Inflammatory Disease Accompanied by Bacterial Inflammagens
Adams, B., Nunes, J. M., Page, M. J., Roberts, T., Carr, J., Nell, T. A., Kell, D. B., & Pretorius, E. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00210 · Cited by 141
Mutant LRRK2 mediates peripheral and central immune responses leading to neurodegeneration in vivo
Kozina, E., Sadasivan, S., Jiao, Y., Dou, Y., Ma, Z., Tan, H., Kodali, K., Shaw, T., Peng, J., & Smeyne, R. J. (2018) · Brain · doi:10.1093/brain/awy077 · Cited by 140
Li, L., Wan, G., Han, B., & Zhang, Z. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.072 · Cited by 132
Interleukin‐17‐producing γδ T ( γδ 17) cells in inflammatory diseases
Akitsu, A., & Iwakura, Y. (2018) · Immunology · doi:10.1111/imm.12993 · Cited by 128
Gaig, C., Ezquerra, M., Marti, M. J., Muñoz, E., Valldeoriola, F., & Tolosa, E. (2006) · Archives of Neurology · doi:10.1001/archneur.63.3.377 · Cited by 122
Kishimoto, Y., Zhu, W. S., Hosoda, W., Sen, J. M., & Mattson, M. P. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-019-08539-5 · Cited by 122
Hanaoka, A., & Kashihara, K. (2009) · Journal of clinical neuroscience · doi:10.1016/j.jocn.2008.12.027 · Cited by 114
Signs of the presence of Th17 cells in chronic periodontal disease
Adibrad, M., Deyhimi, P., Ganjalıkhani-Hakemi, M., Behfarnia, P., Shahabuei, M., & Rafiee, L. (2012) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2011.01464.x · Cited by 97
LRRK2 in peripheral and central nervous system innate immunity: its link to Parkinson's disease
Lee, H., James, W., & Cowley, S. A. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160262 · Cited by 94
Parkinson's disease and periodontitis – the missing link? A review
Kaur, T., Uppoor, A., & Naik, D. (2016) · Gerodontology · doi:10.1111/ger.12188 · Cited by 92
Green, H. F., Khosousi, S., & Svenningsson, P. (2019) · Journal of Parkinson's Disease · doi:10.3233/jpd-191699 · Cited by 83
Novel LRRK2 GTP-binding inhibitors reduced degeneration in Parkinson's disease cell and mouse models
Li, T., Yang, D., Zhong, S., Thomas, J. M., Xue, F., Liu, J., Kong, L., Voulalas, P., Hassan, H. E., Park, J.-S., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu341 · Cited by 83
Dental health of patients with Parkinson's disease in Iceland
Einarsdóttir, E. R., Gunnsteinsdóttir, H., Hallsdóttir, M. H., Sveinsson, S., Jónsdóttir, S. R., Ólafsson, V. G., Bragason, T. H., Sæmundsson, S. R., & Holbrook, W. P. (2009) · Special Care in Dentistry · doi:10.1111/j.1754-4505.2009.00075.x · Cited by 78
Chou, J.-S., Chen, C., Chen, Y., Weng, Y.-H., Yeh, T., Lu, C.-S., Chang, Y.-M., & Wang, H. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.04.021 · Cited by 76
Role of the IL-1 Pathway in Dopaminergic Neurodegeneration and Decreased Voluntary Movement
Stojakovic, A., Paz-Filho, G., Arcos-Burgos, M., Licinio, J., Wong, M.-L., & Mastronardi, C. A. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-9988-x · Cited by 64
Is Porphyromonas gingivalis involved in Parkinson’s disease?
Olsen, I., Kell, D. B., & Pretorius, E. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03944-2 · Cited by 46
Barcia, C., Ros, C. M., Ros‐Bernal, F., Gómez, A., Annese, V., Sauvage, M.-A. C.-D., Yuste, J. E., Campuzano, C. M., de Pablos, V., Fernández‐Villalba, E., et al. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.05.001 · Cited by 45
Linhartová, P. B., Kaštovský, J., Lučanová, S., Bártová, J., Poskerová, H., Vokurka, J., Fassmann, A., Kankova, K., & Hollá, L. I. (2016) · Mediators of Inflammation · doi:10.1155/2016/2979846 · Cited by 41
Odontoblastic Exosomes Attenuate Apoptosis in Neighboring Cells
Wang, H., Yang, F. H., Wang, Y., Pei, F., Chen, Z., & Zhang, L. (2019) · Journal of Dental Research · doi:10.1177/0022034519869580 · Cited by 39
Suresh, M., Czerwinski, S., Murreddu, M. G., Kallakury, B., Ramesh, A., Gudima, S. O., & Menne, S. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1008248 · Cited by 23
A dysfunction of CD4+ T lymphocytes in peripheral immune system of Parkinson's disease model mice.
Huang, Y., Liu, Z., Wang, X., Qiu, Y., & Peng, Y.-P. (2014) · PubMed · Cited by 20
Self-citationInteraction of LRRK2 and α-Synuclein in Parkinson's Disease.
Daher, J. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-49969-7_11 · Cited by 17
The kinase LRRK2 is differently expressed in chronic rhinosinusitis with and without nasal polyps
Ma, Y., Zheng, C., & Shi, L. (2018) · Clinical and Translational Allergy · doi:10.1186/s13601-018-0194-y · Cited by 12
Research works printed but not linked: 1
- Houser MC, Tansey MG. The gut-brain axis: is intestinal inflammation a silent driver of Parkinson's disease pathogenesis? NPJ Parkinsons Dis. 2017;3:3. · DOI · Paper page
Cited by
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders
Sorboni, S. G., Moghaddam, H. S., Jafarzadeh-Esfehani, R., & Soleimanpour, S. (2022) · Clinical Microbiology Reviews · doi:10.1128/cmr.00338-20 · Cited by 522
Oral microbiome: a review of its impact on oral and systemic health
Rajasekaran, J. J., Krishnamurthy, H. K., Bosco, J., Jayaraman, V., Krishna, K., Wang, T., & Bei, K. (2024) · Microorganisms · doi:10.3390/microorganisms12091797 · Cited by 272
The oral–gut microbiome axis in health and disease
Kunath, B. J., De Rudder, C., Laczny, C. C., Letellier, E., & Wilmes, P. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01075-5 · Cited by 316
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Wang, Q., Luo, Y., Ray Chaudhuri, K., Reynolds, R., Tan, E.-K., & Pettersson, S. (2021) · Brain · doi:10.1093/brain/awab156 · Cited by 281
The Oral-Gut-Brain AXIS: The Influence of Microbes in Alzheimer’s Disease
Narengaowa, Kong, W., Lan, F., Awan, M. U. F., Qing, H., & Ni, J. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.633735 · Cited by 149
Metadata
- Authors
- Feng, Y.-K., Wu, Q.-L., Peng, Y.-W., Liang, F.-Y., You, H.-J., Feng, Y.-W., Li, G., Li, X.-J., Liu, S.-H., Li, Y.-C., Zhang, Y., & Pei, Z.
- Affiliations
- Sun Yat-sen University (CN)
- Guangdong Laboratory Animals Monitoring Institute (CN)
- Corresponding author
- Pei, Zhong
- Venue
- Journal of Neuroinflammation
- Published
- 2020-11-19
- Volume
- 17
- Issue
- 1
- Pages
- 347-347
- ISSN
- 1742-2094 (ISSN-L)
- PMC
- PMC7677837
- OpenAlex
- W3103133353
- Cited by
- 87
- References
- 56
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 17 · 2023: 15 · 2022: 14 · 2021: 13 · 2020: 1
- FWCI
- 4.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- Journal of Neuroinflammation (publishedVersion, cc-by)
- Research Square (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Key Research and Development Program of China Stem Cell and Translational Research (2017YFA0105104)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Porphyromonas gingivalis, Parkinson's disease, intestinal permeability, gut dysbiosis, chronic periodontitis, neuroinflammation, dopaminergic neurons, substantia nigra, microglial activation, alpha-synuclein, zonula occludens-1, IL-17A, IL-17RA, TNF-α, IL-1β, lipopolysaccharide, gut-brain axis
- MeSH terms
- Gastrointestinal Microbiome, Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Administration, Oral, Animals, Cells, Cultured, Immunity, Mice, Transgenic, Permeability, Substantia Nigra, Bacteroidaceae Infections, Porphyromonas gingivalis, Microglia, Neurodegenerative Diseases, Mice, Dopaminergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.